Sellas life sciences group, inc. (SLS)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
Net revenue

-

-

-

-

-

-

-

-

0

-

Operating expenses:
Cost of revenue (excluding amortization of certain acquired intangible assets)

-

-

-

-

-

-

-

-

0

-

Research and development employee stock-based compensation expense

-

-

-

-

-

-

-

-

-

1,084

Total research and development expense

-

-

-

-

-

-

-

-

-

743

Research and development

7,285

8,767

6,067

11,395

23,611

27,674

-

-

-

7,873

General and administrative

9,923

12,772

15,089

4,593

10,609

16,226

-

-

-

-

Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)

2,833

9,550

0

-

-

-

-

-

-

-

Research and development

-

-

-

-

-

-

20,424

14,614

3,851

6,046

General and administrative

-

-

-

-

-

-

8,065

6,585

8,635

5,493

Amortization of certain acquired intangible assets

-

-

-

-

-

-

-

-

0

2,541

Fair value of common stock warrants issued for general and administrative expense

-

-

-

-

-

-

-

-

-

718

Total selling, general and administrative expense

-

-

-

-

-

-

-

-

-

8,752

Total operating expenses

-

-

-

-

34,220

43,900

28,489

21,199

12,486

16,625

Severance costs related to Merger

-

-

1,883

-

-

-

-

-

-

-

Total operating expenses and operating loss

20,041

31,089

23,039

-

-

-

-

-

-

-

Operating loss

-

-

-

-15,988

-34,220

-43,900

-28,489

-21,199

-12,486

-

Non-operating income (expense):
Change in fair value of warrant liability

-1,136

-5,300

0

-

-

-

-

-

-

-

Change in fair value of contingent consideration

-586

-3,032

0

-

509

170

-

-

-

-

Loss on settlement of liability-classified warrants

0

727

0

-

-

-

-

-

-

-

Gain (Loss) on Extinguishment of Debt

0

766

0

-

-

-

-

-

-

-

Litigation settlements

-

-

-

-

-5,282

0

0

-

-

-

Change in fair value of warrants potentially settleable in cash

-

-

-

-

-1,162

-16,556

44,001

10,775

-

-

Loss from discontinued operations

-

-

-

-

-

-

-5,351

-1,644

-8,078

-

Interest income (expense), net

118

-266

-462

-1,166

-760

-1,110

-

-

-

-

Income (loss) from continuing operations

-

-

-

-

-38,956

-28,284

-71,327

-33,325

-3,407

-

Total non-operating income (expense), net

668

2,041

-462

-

-

-

-

-

-

-

Interest expense, net

-

-

-

-

-

-

-807

-33

-7

5

Change in fair value of the contingent purchase price liability

-

-

-

-

-

-

3,022

-2,370

9,086

4,627

Loss before income taxes

-19,373

-29,048

-23,501

-

-4,371

15,616

-41,786

-13,178

9,079

4,632

Loss on warrant exchange

-

-

-

-

-1,162

-16,556

-

-

-

-

Other income, net

-

-

-

-

-

-

-

-

-

4,627

Income (loss) from continuing operations from continuing operations before income taxes

-

-

-

-

-38,591

-28,284

-70,275

-34,377

-3,407

-11,993

Other expense

-

-

-

526

-

-

-

-

-

-

Income tax benefit

-81

-1,378

253

1

365

0

1,052

-1,052

0

-

Income (loss) from discontinued operations

-

-

-

-

-24,946

-8,322

-

-

-

-

Net Income (Loss) Attributable to Parent

-19,292

-27,670

-23,754

-17,681

-63,902

-36,606

-76,678

-34,969

-11,485

-11,993

Deemed dividend arising from warrant modifications

8,416

0

-

-

-

-

-

-

-

-

Deemed dividend arising from beneficial conversion feature of convertible preferred stock

0

4,436

0

-

-

-

-

-

-

-

Dividend On Conversion Of Series A Convertible Preferred Stock, Most Favored Nation Net

0

8,700

-

-

-

-

-

-

-

-

Deemed dividend arising from the issuance of common stock to Series A convertible preferred stockholders under most favored nation provision

-

-

0

-

-

-

-

-

-

-

Impact of anti-dilution protection on liability-classified warrants

243

491

0

-

-

-

-

-

-

-

Deemed dividend on conversion of 2015 Sely Note

-

-

675

-

-

-

-

-

-

-

Net loss attributable to common stockholders

-27,951

-41,251

-24,429

-17,681

-

-

-

-

-

-

Per share information:
Net loss

-19,292

-27,670

-23,754

-17,681

-63,902

-36,606

-76,678

-34,969

-11,485

-11,993

Reclassification of unrealized gain upon sale of marketable securities

-

-

-

-

-

-

2,678

0

-

-

Reclassification of unrealized gain upon sale of marketable securities

-

-

-

-

-

-

-

-

0

-

Unrealized gain on marketable securities

-

-

-

-

-

-

-

2,678

0

-

Tax effect of reclassification of unrealized gain upon sale of marketable securities

-

-

-

-

-

-

1,052

0

-

-

Tax effect of reclassification of unrealized gain upon sale of marketable securities

-

-

-

-

-

-

-

-

0

-

Tax effect of unrealized gain on marketable securities

-

-

-

-

-

-

-

1,052

0

-

Total comprehensive loss

-

-

-

-

-

-

-78,304

-33,343

-11,485

-

Basic and diluted per share, continuing operations (usd per share)

-

-

-

-

-5.02

-4.74

-0.79

-0.53

-0.09

-

Basic and diluted loss per share, discontinued operations (usd per share)

-

-

-

-

-3.21

-1.39

-0.06

-0.03

-0.22

-

Net loss per common share attributable to common stockholders, basic and diluted (in dollars per share)

-10.92

-157.72

-10.44

-18.66

-8.23

-6.13

-0.85

-0.56

-0.32

-0.67

Weighted-average common shares outstanding, basic and diluted (in shares)

2,558

261

2,340

947

7,763

5,969

90,181

62,480

36,334

17,883